Search
NewAmsterdam Pharma Company NV
NAMSAdd to Watchlist
27.790USD
-0.670-2.35%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.25BMarket Cap
LossP/E TTM
NewAmsterdam Pharma Company NV's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of NewAmsterdam Pharma Company NV is 6.93, ranking 240 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -15.62, which is -86.82% below the recent high of -2.06 and -62.22% above the recent low of -25.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.